Copyright
©The Author(s) 2015.
World J Hepatol. Sep 18, 2015; 7(20): 2292-2302
Published online Sep 18, 2015. doi: 10.4254/wjh.v7.i20.2292
Published online Sep 18, 2015. doi: 10.4254/wjh.v7.i20.2292
Year | Ref. | Formula |
2000 | Ikeda et al[14] | Z = (0.124) × [γ globulin (%)] + (0.001) × hyaluronic acid (ng/mL) + (0.075) × platelet count (104/μL) + (-0.413) × gender (male = 1, female = 2) + (-2.005) |
The condition is hepatic cirrhosis when Z is positive, and chronic hepatitis when Z is negative | ||
2007 | Koda et al[15] | Fibroindex = (1.738) + (-0.064) × platelet count (104/μL) + (0.005) × AST (IU/L) + (0.463) × [γ globulin (g/dL)] |
The fibroindex value corresponds to fibrosis stage | ||
2003 | Wai et al[16] | APRI = 100 × [AST level/(upper limit of normal AST)/platelet count (× 109/L)] |
2006 | Sterling et al[17] | FIB-4 = [age × AST (U/L)]/[platelet count (× 109/L) × ALT (U/L)1/2] |
- Citation: Nakayama H, Takayama T. Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World J Hepatol 2015; 7(20): 2292-2302
- URL: https://www.wjgnet.com/1948-5182/full/v7/i20/2292.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i20.2292